Bionano Genomics (BNGO) Research & Development (2017 - 2026)

Bionano Genomics has disclosed Research & Development across 10 years of filings, most recently posting $3.1 million for Q1 2026.

• Research & Development for Q1 2026 came in at $3.1 million, up 32.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (down 30.18% YoY), and the FY2025 annual result was $11.4 million, down 54.14% from the prior year.
• Research & Development came in at $3.1 million for Q1 2026 at Bionano Genomics, down from $3.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $14.6 million in Q2 2023 to a low of $2.4 million in Q1 2025.
• The 5-year median for Research & Development is $9.8 million (2024), against an average of $8.4 million.
• Across the five-year window, Research & Development soared 293.09% in 2022 and tumbled 75.76% in 2025, its largest moves.
• Bionano Genomics' Research & Development stood at $14.0 million in 2022, then slipped by 16.49% to $11.7 million in 2023, then slumped by 70.31% to $3.5 million in 2024, then slipped by 7.05% to $3.2 million in 2025, then dropped by 2.79% to $3.1 million in 2026.
• The last three Research & Development figures came in at $3.1 million (Q1 2026), $3.2 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.